Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
0.72Price to Sales
VS
Market
Sector
Industry
History
$ 1.79Close
$ 0.67 - $ 1.82 52-Week Range
Ticker Information
Ticker
CHRSCompany Name
COHERUS ONCOLOGY INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQCOHERUS ONCOLOGY INC - Price to Sales Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
CHRS - P/S Historical data
| Date | Market Capitalization | Price to Sales | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 102.74M | 0.72 | $ 142.77M |
| 3/31/2025 | $ 118.25M | 0.6 | $ 197.5M |
| 12/31/2024 | $ 106.16M | 0.4 | $ 266.96M |
| 9/30/2024 | $ 83.41M | 0.27 | $ 304.34M |
| 6/30/2024 | $ 148.62M | 0.48 | $ 308.13M |
| 3/31/2024 | $ 243.22M | 0.81 | $ 301.87M |
| 12/31/2023 | $ 250.23M | 0.97 | $ 257.24M |
| 9/30/2023 | $ 394.23M | 1.87 | $ 211.07M |
| 6/30/2023 | $ 409.99M | 2.25 | $ 181.93M |
| 3/31/2023 | $ 655.71M | 3.58 | $ 183.36M |
Key Performance Insights, Last 5 Years
- COHERUS ONCOLOGY INC's latest trailing twelve months (TTM) P/S stands at 2.69.
- Over the past 5 years, COHERUS ONCOLOGY INC's average P/S has been 1.93.
- The median P/S for COHERUS ONCOLOGY INC during this period was 2.29
- COHERUS ONCOLOGY INC reached its highest P/S over the past 5 years at 3.7.
- The lowest P/S recorded by COHERUS ONCOLOGY INC in the same timeframe 0.27
COHERUS ONCOLOGY INC's P/S vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/S Benchmarks
Similar metrics to Revenues:
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Price to Book - [Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].
- Enterprise Value over Free Cash Flow - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
Definition of Price to Sales
[Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].Market Cap / Revenues
(=) P/S P/S for COHERUS ONCOLOGY INC is calculated as follows: Market Cap [ $ 1.32B ] / Revenues [ $ 489.26M ]
(=) P/S [ 2.69 ] CHRS - Price to Sales, Last 5 years
0.27
Minimum
Sep 30, 2024
3.7
Maximum
Sep 30, 2021
1.93
Average
2.29
Median
P/S Benchmark AnalysisMarket
The chart above depicts the distribution of P/S for companies in the Total Stock Market. The average P/S of the companies is 2.62 with a standard deviation of 2.38.
The following table provides additional summary stats:
P/S in the Market:
| filtered constituents | 3.41K |
|---|---|
| min | 0 |
| max | 11.15 |
| average | 2.62 |
| median | 1.97 |
| std | 2.38 |